These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 38671369)
1. Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer. Liu X; Li J; Huang Q; Jin M; Huang G Mol Med; 2024 Apr; 30(1):56. PubMed ID: 38671369 [TBL] [Abstract][Full Text] [Related]
2. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2. Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis. Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748 [No Abstract] [Full Text] [Related]
4. Rh2-enriched Korean ginseng (Ginseng Rh2+) inhibits tumor growth and development of metastasis of non-small cell lung cancer. Lev-Ari S; Starr AN; Vexler A; Kalich-Philosoph L; Yoo HS; Kwon KR; Yadgar M; Bondar E; Bar-Shai A; Volovitz I; Schwarz Y Food Funct; 2021 Sep; 12(17):8068-8077. PubMed ID: 34286798 [TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling. Ma J; Zhao D; Yu D; Song W; Yang X; Yin H Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781 [TBL] [Abstract][Full Text] [Related]
6. Novel ginsenoside derivative 20(S)-Rh2E2 suppresses tumor growth and metastasis in vivo and in vitro via intervention of cancer cell energy metabolism. Huang Q; Zhang H; Bai LP; Law BYK; Xiong H; Zhou X; Xiao R; Qu YQ; Mok SWF; Liu L; Wong VKW Cell Death Dis; 2020 Aug; 11(8):621. PubMed ID: 32796841 [TBL] [Abstract][Full Text] [Related]
8. Synergistic anticancer effects of ginsenoside CK and gefitinib against gefitinib-resistant NSCLC by regulating the balance of angiogenic factors through HIF-1α/VEGF. Song X; Wang L; Cai P; Xu Y; Liu Q; Fan D Toxicol Appl Pharmacol; 2024 May; 486():116938. PubMed ID: 38642809 [TBL] [Abstract][Full Text] [Related]
9. Albendazole inhibits HIF-1α-dependent glycolysis and VEGF expression in non-small cell lung cancer cells. Zhou F; Du J; Wang J Mol Cell Biochem; 2017 Apr; 428(1-2):171-178. PubMed ID: 28063005 [TBL] [Abstract][Full Text] [Related]
10. NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells. Zeng C; Wu Q; Wang J; Yao B; Ma L; Yang Z; Li J; Liu B Free Radic Biol Med; 2016 Dec; 101():236-248. PubMed ID: 27989748 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA LINC00243 promotes proliferation and glycolysis in non-small cell lung cancer cells by positively regulating PDK4 through sponging miR-507. Feng X; Yang S Mol Cell Biochem; 2020 Jan; 463(1-2):127-136. PubMed ID: 31595421 [TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rh2 Inhibited Proliferation by Inducing ROS Mediated ER Stress Dependent Apoptosis in Lung Cancer Cells. Ge G; Yan Y; Cai H Biol Pharm Bull; 2017 Dec; 40(12):2117-2124. PubMed ID: 28966297 [TBL] [Abstract][Full Text] [Related]
13. Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer. De Rosa V; Iommelli F; Monti M; Fonti R; Votta G; Stoppelli MP; Del Vecchio S Clin Cancer Res; 2015 Nov; 21(22):5110-20. PubMed ID: 26216352 [TBL] [Abstract][Full Text] [Related]
14. Ginsenoside compound K inhibits growth of lung cancer cells via HIF-1α-mediated glucose metabolism. Chen HF; Wu LX; Li XF; Zhu YC; Wang WX; Xu CW; Huang ZZ; Du KQ Cell Mol Biol (Noisy-le-grand); 2019 Apr; 65(4):48-52. PubMed ID: 31078152 [TBL] [Abstract][Full Text] [Related]
15. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming. Jin J; Qiu S; Wang P; Liang X; Huang F; Wu H; Zhang B; Zhang W; Tian X; Xu R; Shi H; Wu X J Exp Clin Cancer Res; 2019 Aug; 38(1):377. PubMed ID: 31455352 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway. Gong T; Cui L; Wang H; Wang H; Han N J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734 [TBL] [Abstract][Full Text] [Related]
17. Aldolase A promotes proliferation and G Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507 [TBL] [Abstract][Full Text] [Related]
18. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase. Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of pyruvate dehydrogenase kinase 1 enhances the anti-cancer effect of EGFR tyrosine kinase inhibitors in non-small cell lung cancer. Yang Z; Zhang SL; Hu X; Tam KY Eur J Pharmacol; 2018 Nov; 838():41-52. PubMed ID: 30213498 [TBL] [Abstract][Full Text] [Related]
20. The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis. Li G; Li M; Hu J; Lei R; Xiong H; Ji H; Yin H; Wei Q; Hu G Oncogene; 2017 Feb; 36(7):989-998. PubMed ID: 27641336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]